Key Highlights
- Expanded Library: Includes new digital solutions for Parkinson’s disease (PD) research.
- Four Key Areas: Sleep, Alzheimer’s disease and related dementias (ADRD), physical activity (PA), and PD.
- Future Partnerships: Commitment to expanding into other therapeutic areas.
- Collaborative Effort: Involvement of DiMe, MJFF, and C-Path to advance digital health technologies.
- Comprehensive Tools: Facilitates superior monitoring, early diagnosis, and innovative care for PD.
Source: PR Newswire
Notable Quotes
- “Broad adoption of high-quality, fit-for-purpose digital measurement products promises to speed the inclusive development of new PD therapies, improve access to PD trials and specialist care by supporting decentralized and virtual research and care models, support earlier diagnoses, and improve outcomes through the identification of digital phenotypes.” — Jennifer Goldsack, CEO at DiMe
- “The release of this centralized, open-source resource is a critical step forward for clinicians, developers, or researchers looking for evidence-based tools. The data sets give users the information needed to expedite timelines, facilitate assessment of the landscape for sensor-based digital health technologies, and allow benchmarking of digital innovation in PD to other related therapeutic areas, which was previously inaccessible.” — Yuge Xiao, Clinical Research Lead at MJFF
- “Sensor-based digital health technologies can bridge this gap by enabling remote and frequent measurement of PD symptoms, supporting early intervention, innovative treatments, and improved outcomes for patients. Collaborative approaches to collecting and cataloging this information, and making it broadly accessible, will help advance the field in unprecedented ways.” — Diane Stephenson, Executive Director at CPP
SoHC's Take
The enhancement of DATAcc by DiMe’s Library of Digital Measurement Products represents a significant step forward in the field of Parkinson’s disease research and care. By integrating comprehensive digital tools specifically designed for PD, the collaborative effort between DiMe, MJFF, and C-Path addresses critical needs in monitoring and treating this complex condition. This resource not only accelerates research and development but also ensures that high-quality, evidence-based digital health technologies are accessible to clinicians, researchers, and developers. This expansion underscores the potential of digital health technologies to transform patient care and outcomes, fostering a future where early diagnosis and innovative treatments for Parkinson’s disease are readily achievable.
